Family history of coronary heart disease is associated with a higher incidence of nonalcoholic fatty liver disease: Central obesity the likely link

Obesity Research and Clinical Practice

Volumn 1, Issue 2, 2007, Pages 125-131

  Zhang, Lei ^a   Pu, Kui ^a   Chai, Zhonglin ^b   Dixon, John B ^c  

^a NANKAI UNIVERSITY   (China)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Coronary heart disease; Family history; Fatty liver disease; Metabolic syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOGRAPHY; FAMILY HISTORY; FEMALE; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OFFICE WORKER; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE;

EID: 34247369805     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2007.03.001     Document Type: Article

References (19)

1. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 (2003) 960-967
2. Kojima S., Watanabe N., Numata M., Ogawa T., and Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 38 (2003) 954-961
3. Dixon J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001) 91-100
4. Willner I.R., Waters B., Patil S.R., Reuben A., Morelli J., and Riely C.A. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96 (2001) 2957-2961
5. Weston S.R., Leyden W., Murphy R., Bass N.M., Bell B.P., Manos M.M., et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41 (2005) 372-379
6. Valenti L., Fracanzani A.L., Dongiovanni P., Santorelli G., Branchi A., Taioli E., et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122 (2002) 274-280
7. Dixon J.B., Bhathal P.S., Jonsson J.R., Dixon A.F., Powell E.E., and O'Brien P.E. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 39 (2003) 967-971
8. Poullis A.P., Shetty A.K., Risley P.D., Collinson P.O., and Mendall M.A. Effect of the CD14 promoter polymorphism on liver function tests and its association with alcohol and obesity. Eur J Gastroenterol Hepatol 15 (2003) 1317-1322
9. Gupte P., Amarapurkar D., Agal S., Baijal R., Kulshrestha P., Pramanik S., et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 19 (2004) 854-858
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
11. Saverymuttu S.H., Joseph A.E., and Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 292 (1986) 13-15
12. Day C.P. The potential role of genes in nonalcoholic fatty liver disease. Clin Liver Dis 8 (2004) 673-691
13. Medina J., Fernandez-Salazar L.I., Garcia-Buey L., and Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diab Care 27 (2004) 2057-2066
14. Glowinska B., Urban M., and Koput A. Cardiovascular risk factors in children with obesity, hypertension and diabetes: lipoprotein (a) levels and body mass index correlate with family history of cardiovascular disease. Eur J Pediatr 161 (2002) 511-518
15. Brea A., Mosquera D., Martin E., Arizti A., Cordero J.L., and Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 25 (2005) 1045-1050
16. Targher G., Bertolini L., Padovani R., Zenari L., Zoppini G., and Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diab Care 27 (2004) 2498-2500
17. Volzke H., Robinson D.M., Kleine V., Deutscher R., Hoffmann W., Ludemann J., et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 11 (2005) 1848-1853
18. Gu D., et al., InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
19. Grundy S.M., et al., American Heart Association. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart Lung and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 13 (2005) 322-327